2nd Edition of International Cancer Research Conference
March 19-21, 2026 | Singapore
Adenoid Cystic Carcinoma
Adenoid cystic carcinoma (ACC) is a rare and aggressive form of cancer that typically arises in the salivary glands, but can also occur in other areas such as the breast, trachea, or lungs. Despite its rarity, ACC poses significant challenges due to its slow growth and tendency to spread to distant organs, particularly the lungs. Research efforts in cancer biology and treatment strategies are intensifying to combat this disease. Scientists are investigating the genetic mutations and molecular pathways underlying ACC to identify potential targets for therapy. Immunotherapy, targeted therapies, and combination treatments are being explored in clinical trials to improve outcomes for patients with ACC. Moreover, advances in precision medicine hold promise for tailoring treatments to the individual characteristics of each patient's tumor, offering new hope in the fight against this challenging cancer.
Rajvir Dahiya
University of California San Francisco, United States
Anyou Wang
DIFIBER LLC, United States
Michael Thompson
University of Toronto, Canada
Can Küçük
Dokuz Eylul University, Turkey
Nadia Leney Olazo Marquez
Benemérita Universidad Autónoma de Puebla, Mexico
Liu Ying
Shanghai University, China
Ratan Kumar Sarkar
Independent Researcher, IndiaSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Mudalsha Ravina, All India Institute of Medical Sciences, India
Title : Transforming cancer care: Innovations, integrations, and impact
Shayan Maqsood, Jamia Hamdard University, India
Title : Updates on controversies surrounding the staging and management of newly diagnosed localized prostate cancer using prostate-specific membrane antigen (PSMA) positron emission tomography
Patricia Tai, University of Saskatchewan, Canada
Title : Advanced nanoparticles, the hallmark of targeted drug delivery for osteosarcoma
Shayan Maqsood, Jamia Hamdard University, India